News Headlines Article

Lawmakers revive Creates Act opposed by Big Pharma
Modern Healthcare

House and Senate lawmakers reintroduced a bill on Tuesday to combat tactics brand-name drug companies use to stymie generic and biosimilar competition.

Sens. Chuck Grassley (R-Iowa) and Patrick Leahy (D-Vt.) reintroduced the Creating and Restoring Equal Access to Equivalent Samples Act, or Creates Act, which generated immense opposition from the pharmaceutical industry.

“For too long, a few predatory name brand companies have used anticompetitive strategies to delay entry of lower cost generic drugs,” Leahy said in a statement. “When these companies use unfair practices to keep drug prices artificially high, patients suffer.”